Literature DB >> 11005473

Bacterial vaginosis increases in pessary users.

B Alnaif1, H P Drutz.   

Abstract

The purpose of this study was to examine the association between pessary use, smoking and changes in the vaginal flora. Patients using pessaries were age matched with non-pessary using controls. All candidates examined were women attending the Mount Sinai Hospital, Toronto, for genitourinary problems. Vaginal cultures were routinely performed on all women attending the unit, irrespective of symptoms. Forty-four pessary users were age matched with 176 controls (4 controls per case). The mean age was 60.1 +/- 12.6 years, and 15% of these were premenopausal. The duration of pessary use ranged from 0.5 to 8 years (mean 3.3 +/- 1.7). Weight, parity, smoking status, diabetes mellitus, thyroid disease, UTI and postvoid residual urine volume were not significantly different between pessary users and controls. Bacterial vaginosis (BV) was noted in 32% of pessary users, versus 10% of controls. The relative risk of developing BV in pessary users was 3.3 (OR, 4.37; 95% CI, 2.15-9.32), P = 0.0002. Smoking independently affected the vaginal flora, increasing the relative risk of developing BV to 2.9 (OR, 3.78; 95% CI, 2.05-8.25), P = 0.0013. It was concluded that pessary use is a very effective and conservative method for the treatment of genital prolapse. However, we found that the presence of a foreign body was associated with changes in the vaginal flora, thereby increasing the odds of developing bacterial vaginosis to 4.37; this was further compounded by smoking.

Entities:  

Mesh:

Year:  2000        PMID: 11005473     DOI: 10.1007/pl00004026

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  6 in total

1.  Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States.

Authors:  Joscelyn N Hoffmann; Hannah M You; E C Hedberg; Jeanne A Jordan; Martha K McClintock
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2014-11       Impact factor: 4.077

2.  Effects of pelvic organ prolapse ring pessary therapy on intravaginal microbial flora.

Authors:  Kazuaki Yoshimura; Nobuo Morotomi; Kazumasa Fukuda; Toru Hachisuga; Hatsumi Taniguchi
Journal:  Int Urogynecol J       Date:  2015-09-16       Impact factor: 2.894

Review 3.  An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse.

Authors:  Marwa Abdulaziz; Lynn Stothers; Darren Lazare; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

4.  The effect of hydroxyquinoline-based gel on pessary-associated bacterial vaginosis: a multicenter randomized controlled trial.

Authors:  Kate V Meriwether; Rebecca G Rogers; Ellen Craig; Sean D Peterson; Robert E Gutman; Cheryl B Iglesia
Journal:  Am J Obstet Gynecol       Date:  2015-04-30       Impact factor: 8.661

5.  Changes in the Vaginal Microenvironment as Related to Frequency of Pessary Removal.

Authors:  Nicole J Fregosi; Deslyn T G Hobson; Casey L Kinman; Jeremy T Gaskins; J Ryan Stewart; Kate V Meriwether
Journal:  Female Pelvic Med Reconstr Surg       Date:  2018 Mar/Apr       Impact factor: 2.091

6.  Bacterial biofilm formation on vaginal ring pessaries used for pelvic organ prolapse.

Authors:  Felicity G Gould; Marcus P Carey; Erica L Plummer; Gerald L Murray; Jennifer A Danielewski; Sepehr N Tabrizi; Suzanne M Garland
Journal:  Int Urogynecol J       Date:  2021-03-03       Impact factor: 2.894

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.